{"DataElement":{"publicId":"62590","version":"3","preferredName":"Agent Course Count","preferredDefinition":"the total number of cycles administered to the patient.","longName":"AGT_CRSE_CT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2014028","version":"1","preferredName":"Agent Course","preferredDefinition":"the course or cycle of a therapeutic agent or drug.","longName":"AGT_CRSE","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2223333","version":"1","preferredName":"Agent","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B10F2-76A7-2830-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177604","version":"1","preferredName":"Course","preferredDefinition":"Course; a connected series of events or actions or developments","longName":"Course","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Course","conceptCode":"C25379","definition":"Passage through time; duration; a systematic or/and orderly succession; a sequence, e.g. course of treatment; a mode of action or behavior; natural development, typical manner of proceeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51B4-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30ABBEE-C176-1192-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Use caBIG NCIt based OC instead. - dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018392","version":"1","preferredName":"Count","preferredDefinition":"The quantity of the specified item.","longName":"CT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261845","version":"1","preferredName":"Count","preferredDefinition":"To determine the number or amount of something; the result of this activity.","longName":"C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-646B-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-13","modifiedBy":"ONEDATA","dateModified":"2005-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B3BF4389-4489-5F2C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-09","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-08","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/11/17 tt transferred context, added reg status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"},{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"},{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"},{"publicId":"10000607","version":"1","longName":"Sarcoma","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812383","version":"1","longName":"AdEERS","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"},{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811919","version":"1","longName":"Advanced Melanoma","context":"CTEP"},{"publicId":"2811927","version":"1","longName":"Local-Reg Melanoma","context":"CTEP"},{"publicId":"2811904","version":"1","longName":"Multiple Myeloma","context":"CTEP"},{"publicId":"2811905","version":"1","longName":"Primary Amyloidosis","context":"CTEP"},{"publicId":"2811906","version":"1","longName":"Waldenstrom Macrogl","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2190530","version":"1","longName":"Demonstration Applications","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812349","version":"1","longName":"Rembrandt","context":"NCIP"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3449457","version":"1","longName":"Study Agent Administration","context":"NCIP"},{"publicId":"2867243","version":"1","longName":"Prior/Post Therapies CRF","context":"NCIP"},{"publicId":"2812342","version":"1","longName":"Proposed","context":"NCIP"},{"publicId":"2812976","version":"1","longName":"LOINC Lab Tests","context":"NCIP"}]},{"publicId":"2201295","version":"1","longName":"Clinical Trials Branch","context":"CIP","ClassificationSchemeItems":[{"publicId":"2812387","version":"1","longName":"AE/SAE CDEs","context":"CIP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000210","version":"1","longName":"AdEERS","context":"CTEP"},{"publicId":"2812624","version":"1","longName":"Breast Cancer Data Mart","context":"CTEP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787505","version":"1","longName":"HNSC","context":"NCIP"},{"publicId":"3787508","version":"1","longName":"KIRP","context":"NCIP"},{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787514","version":"1","longName":"OV","context":"NCIP"},{"publicId":"3787516","version":"1","longName":"PRAD","context":"NCIP"},{"publicId":"3787502","version":"1","longName":"CESC","context":"NCIP"},{"publicId":"3787503","version":"1","longName":"COAD","context":"NCIP"},{"publicId":"3787504","version":"1","longName":"GBM","context":"NCIP"},{"publicId":"3787506","version":"1","longName":"KICH","context":"NCIP"},{"publicId":"3787507","version":"1","longName":"KIRC","context":"NCIP"},{"publicId":"3787499","version":"1","longName":"BLCA","context":"NCIP"},{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"},{"publicId":"3787510","version":"1","longName":"LGG","context":"NCIP"},{"publicId":"3787509","version":"1","longName":"LAML","context":"NCIP"},{"publicId":"3787511","version":"1","longName":"LIHC","context":"NCIP"},{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"},{"publicId":"3787517","version":"1","longName":"READ","context":"NCIP"},{"publicId":"3787518","version":"1","longName":"SARC","context":"NCIP"},{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"},{"publicId":"3787522","version":"1","longName":"UCEC","context":"NCIP"},{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"},{"publicId":"3787515","version":"1","longName":"PAAD","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"3896537","version":"1","longName":"UWI2013-01-02","context":"DCP"}]},{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"6643183","version":"1","longName":"Systemic Therapy","context":"MCL"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635322","version":"1","longName":"Prior/Post Therapies","context":"NCI Standards"},{"publicId":"10000582","version":"1","longName":"Study Agent Administration","context":"NCI Standards"}]},{"publicId":"5655939","version":"1","longName":"BLGSP (Burkitt Lymphoma Genome Sequencing Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000268","version":"1","longName":"Initial Treatment and Followup Form","context":"OCG"}]},{"publicId":"7434158","version":"1","longName":"CTEP CDISC Harmonization","context":"CTEP","ClassificationSchemeItems":[{"publicId":"7590139","version":"1","longName":"CTEP CDISC Study Treatment Administration","context":"CTEP"}]}],"AlternateNames":[{"name":"0064796","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"AGT_CRSE_CT","type":"USED_BY","context":"CIP"},{"name":"AGT_CRSE_CT","type":"USED_BY","context":"CCR"},{"name":"AGT_CRSE_CT","type":"USED_BY","context":"NCIP"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"Number Cycles","type":"TCGA_Name","context":"NCIP"},{"name":"number_cycles","type":"TCGA_XML_Name","context":"NCIP"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"AGT_CRSE_CT","type":"USED_BY","context":"OHSU Knight"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"AGT_CRSE_CT","type":"USED_BY","context":"CITN"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"FAEC_FAORRES_TOTCSN","type":"CTEP CDISC CDE","context":"CTEP"}],"ReferenceDocuments":[{"name":"CRF Text1","type":"Alternate Question Text","description":"Total No. of Courses Administered","url":null,"context":"CTEP"},{"name":"COMMENT_356","type":"COMMENT","description":"Add instruction: (of protocol specified agent)","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Agent Count Courses Administered","url":null,"context":"CTEP"},{"name":"Total # of Courses Received","type":"Preferred Question Text","description":"Total # of Courses Received","url":null,"context":"CTEP"},{"name":"Number of Cycles","type":"Alternate Question Text","description":"Number of Cycles","url":null,"context":"NCIP"},{"name":"CRF Text 2","type":"Alternate Question Text","description":"Number of Cycles/Doses Received","url":null,"context":"CTEP"},{"name":"CRF Text 3","type":"Alternate Question Text","description":"Total number during interval period","url":null,"context":"CTEP"},{"name":"ECOG CRF Text 1","type":"Alternate Question Text","description":"Number of Cycles Received","url":null,"context":"ECOG-ACRIN"},{"name":"DCP Text - 1","type":"Alternate Question Text","description":"# of Cycles","url":null,"context":"DCP"},{"name":"CITN","type":"Alternate Question Text","description":"Total number of Courses/Cycles received","url":null,"context":"CITN"},{"name":"NRG_CRF_TEXT1","type":"Alternate Question Text","description":"If yes, number of cycles","url":null,"context":"NRG"},{"name":"MCL-Breast-1","type":"Alternate Question Text","description":"Neoadjuvant Chemotherapy cycles complete","url":null,"context":"MCL"},{"name":"COG CRF Text 02","type":"Alternate Question Text","description":"If patient received nelarabine as part of front-line therapy (e.g. before relapse), how many courses did they receive?","url":null,"context":"COG"},{"name":"COG CRF Text 01","type":"Alternate Question Text","description":"If Yes, how many cycles were received?","url":null,"context":"COG"},{"name":"COG CRF TEXT 3","type":"Alternate Question Text","description":"How many doses were received?","url":null,"context":"COG"},{"name":"CTEP Text 1","type":"Alternate Question Text","description":"What was the total number of courses received?","url":null,"context":"CTEP"},{"name":"CTEP Text 2","type":"Alternate Question Text","description":"Total number of courses received","url":null,"context":"CTEP"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"How many cycles of therapy has patient received prior to study enrollment?","url":null,"context":"COG"}],"origin":"ADEERS:NCI/CTEP Adverse Event Expedited Report System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"BD2AB998-530C-2941-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-08","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-08","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":"ISO 11179 compliance..  Alternate question text added per 3/10/2010 request of G. Diaz.","administrativeNotes":"2023.3.7 AQT added per ticket request CADSR0002119. ak 10/20/22 added 1 alt name, 2 AQTs, 1 classification for the CTEP CDISC Harmonization project cjl;","unresolvedIssues":null,"deletedIndicator":"No"}}